Global Decentralized Clinical Trials (DCTs) Market Size, Status and Forecast 2024-2034
Global Decentralized Clinical Trials (DCTs) Scope and Market Size
Decentralized Clinical Trials (DCTs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Decentralized Clinical Trials (DCTs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Interventional
Observational
Expanded Access
Segment by Application
Oncology
Cardiovascular
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37

Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Interventional
1.2.3 Observational
1.2.4 Expanded Access
1.3 Market by Application
1.3.1 Global Decentralized Clinical Trials (DCTs) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Decentralized Clinical Trials (DCTs) Market Perspective (2016-2027)
2.2 Decentralized Clinical Trials (DCTs) Growth Trends by Regions
2.2.1 Decentralized Clinical Trials (DCTs) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Decentralized Clinical Trials (DCTs) Historic Market Share by Regions (2016-2021)
2.2.3 Decentralized Clinical Trials (DCTs) Forecasted Market Size by Regions (2022-2027)
2.3 Decentralized Clinical Trials (DCTs) Industry Dynamic
2.3.1 Decentralized Clinical Trials (DCTs) Market Trends
2.3.2 Decentralized Clinical Trials (DCTs) Market Drivers
2.3.3 Decentralized Clinical Trials (DCTs) Market Challenges
2.3.4 Decentralized Clinical Trials (DCTs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue
3.1.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue (2016-2021)
3.1.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Players (2016-2021)
3.2 Global Decentralized Clinical Trials (DCTs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Decentralized Clinical Trials (DCTs) Revenue
3.4 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio
3.4.1 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trials (DCTs) Revenue in 2020
3.5 Decentralized Clinical Trials (DCTs) Key Players Head office and Area Served
3.6 Key Players Decentralized Clinical Trials (DCTs) Product Solution and Service
3.7 Date of Enter into Decentralized Clinical Trials (DCTs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Decentralized Clinical Trials (DCTs) Breakdown Data by Type
4.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Type (2016-2021)
4.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2022-2027)
5 Decentralized Clinical Trials (DCTs) Breakdown Data by Application
5.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Application (2016-2021)
5.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Decentralized Clinical Trials (DCTs) Market Size (2016-2027)
6.2 North America Decentralized Clinical Trials (DCTs) Market Size by Type
6.2.1 North America Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2021)
6.2.2 North America Decentralized Clinical Trials (DCTs) Market Size by Type (2022-2027)
6.2.3 North America Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2027)
6.3 North America Decentralized Clinical Trials (DCTs) Market Size by Application
6.3.1 North America Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2021)
6.3.2 North America Decentralized Clinical Trials (DCTs) Market Size by Application (2022-2027)
6.3.3 North America Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2027)
6.4 North America Decentralized Clinical Trials (DCTs) Market Size by Country
6.4.1 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2016-2021)
6.4.2 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Decentralized Clinical Trials (DCTs) Market Size (2016-2027)
7.2 Europe Decentralized Clinical Trials (DCTs) Market Size by Type
7.2.1 Europe Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2021)
7.2.2 Europe Decentralized Clinical Trials (DCTs) Market Size by Type (2022-2027)
7.2.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2027)
7.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Application
7.3.1 Europe Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2021)
7.3.2 Europe Decentralized Clinical Trials (DCTs) Market Size by Application (2022-2027)
7.3.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2027)
7.4 Europe Decentralized Clinical Trials (DCTs) Market Size by Country
7.4.1 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2016-2021)
7.4.2 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size (2016-2027)
8.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Type
8.2.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2027)
8.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Application
8.3.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2027)
8.4 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region
8.4.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Decentralized Clinical Trials (DCTs) Market Size (2016-2027)
9.2 Latin America Decentralized Clinical Trials (DCTs) Market Size by Type
9.2.1 Latin America Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2021)
9.2.2 Latin America Decentralized Clinical Trials (DCTs) Market Size by Type (2022-2027)
9.2.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2027)
9.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Application
9.3.1 Latin America Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2021)
9.3.2 Latin America Decentralized Clinical Trials (DCTs) Market Size by Application (2022-2027)
9.3.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2027)
9.4 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country
9.4.1 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2016-2021)
9.4.2 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size (2016-2027)
10.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Type
10.2.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Type (2016-2027)
10.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Application
10.3.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Application (2016-2027)
10.4 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country
10.4.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medidata
11.1.1 Medidata Company Details
11.1.2 Medidata Business Overview
11.1.3 Medidata Decentralized Clinical Trials (DCTs) Introduction
11.1.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.1.5 Medidata Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Details
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction
11.2.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.2.5 IQVIA Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Decentralized Clinical Trials (DCTs) Introduction
11.3.4 Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.3.5 Labcorp Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Details
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction
11.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.4.5 PRA Health Sciences Recent Development
11.5 Parexel
11.5.1 Parexel Company Details
11.5.2 Parexel Business Overview
11.5.3 Parexel Decentralized Clinical Trials (DCTs) Introduction
11.5.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.5.5 Parexel Recent Development
11.6 ICON
11.6.1 ICON Company Details
11.6.2 ICON Business Overview
11.6.3 ICON Decentralized Clinical Trials (DCTs) Introduction
11.6.4 ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.6.5 ICON Recent Development
11.7 Oracle
11.7.1 Oracle Company Details
11.7.2 Oracle Business Overview
11.7.3 Oracle Decentralized Clinical Trials (DCTs) Introduction
11.7.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.7.5 Oracle Recent Development
11.8 CRF Health
11.8.1 CRF Health Company Details
11.8.2 CRF Health Business Overview
11.8.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction
11.8.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.8.5 CRF Health Recent Development
11.9 Clinical Ink
11.9.1 Clinical Ink Company Details
11.9.2 Clinical Ink Business Overview
11.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction
11.9.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.9.5 Clinical Ink Recent Development
11.10 Medable
11.10.1 Medable Company Details
11.10.2 Medable Business Overview
11.10.3 Medable Decentralized Clinical Trials (DCTs) Introduction
11.10.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.10.5 Medable Recent Development
11.11 Science 37
11.11.1 Science 37 Company Details
11.11.2 Science 37 Business Overview
11.11.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction
11.11.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2016-2021)
11.11.5 Science 37 Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details